ILNews

DTCI: The broad scope of MDA preemption

Back to TopCommentsE-mailPrintBookmark and Share

Twohy No photoThe Medical Device Amend-ments of 1976 to the Food, Drug, and Cosmetics Act (MDA) authorized the federal Food and Drug Administration to regulate medical devices while preempting state efforts to enforce any legal requirement that (1) relates to the device’s safety, effectiveness, or other matters committed to the FDA and (2) “is different from, or in addition to,” any requirement imposed under the MDA. 21 U.S.C. § 360k(a).

In a series of decisions culminating in Riegel v. Medtronic, Inc., 128 S. Ct. 999, 1008 (2008), federal courts came to recognize that the MDA preempted not only traditional products liability claims such as those based on an alleged defect or implied warranty but also causes of action premised on theories such as consumer fraud. Since any legal “requirement” for a device that is “different from, or in addition to” that imposed by the MDA (or FDA in its regulatory capacity) is preempted, the only way to avoid preemption is to allege a failure to meet FDA requirements.

The broad scope of MDA preemption has become apparent as District courts around the country have applied § 360k(a), as interpreted in Riegel, to dispose of one products liability case after another, all of which allege injuries from Class III medical devices and seek recovery under various theories, including strict products liability, breach of warranty, and negligence. In general, claims that have alleged something other than a failure by the device manufacturer to adhere to FDA requirements with respect to the device at issue (either with respect to its manufacture or the directions for its use) have been dismissed on preemption grounds.

Congress may amend § 360k to overrule Riegel. The Medical Device Safety Act of 2008, H.R. 1346, currently before the House Subcommittee on Health, would add a new subsection (c) to § 360k (entitled “No Effect on Liability under State Law”) to make clear that “[n]othing in this section [360k] shall be construed to modify or otherwise affect any action for damages or the liability of any person under the law of any State.” (An identical bill, S. 540, is pending before the Senate Committee on Health, Education, Labor and Pensions.) The enactment of the bill has been identified as a top legislative priority by the American Association for Justice.

Nonetheless, pending congressional action, Riegel applies to bar even claims by plaintiffs who have suffered injuries caused by devices that malfunctioned or were arguably defective in their manufacture. In one of the many post-Riegel cases that illustrate this phenomenon, a New Jersey District Court recently granted summary judgment for the defendant manufacturer of a Class III device that was alleged to have injured the plaintiff, where the plaintiff failed to present admissible evidence that the manufacturer had deviated from FDA requirements when it manufactured the device. Banner v. Cyberonics, Inc., 2010 WL 455286 (D.N.J. Feb. 4, 2010). In unusually blunt language, the court emphatically rejected plaintiff’s argument that the device, an implantable VNS therapy unit, could be manufactured according to FDA requirements yet still contain an “anomaly” leading to plaintiff’s injury that would support liability on a non-preempted theory.

Applying Riegel to grant the manufacturer’s summary judgment motion, the court observed that “[t]he FDA approves the process by which a Class III device is manufactured, but it does not guarantee that every device manufactured in that process will work. Thus, if the FDA approves a manufacturing process and the defendant-manufacturer conforms with it, a device thereby produced that nevertheless does not function as intended does not give rise to liability.” Banner, 2010 WL 455286 at *4. The fact that a device may in fact be “defective” (differing from its design in a way that may cause it to malfunction) does not take it outside the scope of MDA preemption. As the court recognized, “[i]t is distinctly possible that the FDA-approved process introduces a margin of error wherein a properly manufactured device may nevertheless depart from its intended design. Under Riegel, state law cannot capture this departure and create liability for it because that would, in effect, require the manufacturer to use greater care than required by the FDA.” Banner at *4. The scope of MDA preemption thus parallels the risk calculus employed by FDA in determining whether to grant premarket approval for a Class III medical device.•

__________

John P. Twohy is a partner in the Hammond office of Eichhorn & Eichhorn and is a director of the DTCI. The opinions expressed in this article are those of the author.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in Indiana Lawyer editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT
Subscribe to Indiana Lawyer
  1. Hmmmmm ..... How does the good doctor's spells work on tyrants and unelected bureacrats with nearly unchecked power employing in closed hearings employing ad hoc procedures? Just askin'. ... Happy independence day to any and all out there who are "free" ... Unlike me.

  2. Today, I want to use this opportunity to tell everyone about Dr agbuza of agbuzaodera(at)gmail. com, on how he help me reunited with my husband after 2 months of divorce.My husband divorce me because he saw another woman in his office and he said to me that he is no longer in love with me anymore and decide to divorce me.I seek help from the Net and i saw good talk about Dr agbuza and i contact him and explain my problem to him and he cast a spell for me which i use to get my husband back within 2 days.am totally happy because there is no reparations and side-effect. If you need his help Email him at agbuzaodera(at)gmail. com

  3. The practitioners and judges who hail E-filing as the Saviour of the West need to contain their respective excitements. E-filing is federal court requires the practitioner to cram his motion practice into pigeonholes created by IT people. Compound motions or those seeking alternative relief are effectively barred, unless the practitioner wants to receive a tart note from some functionary admonishing about the "problem". E-filing is just another method by which courts and judges transfer their burden to practitioners, who are the really the only powerless components of the system. Of COURSE it is easier for the court to require all of its imput to conform to certain formats, but this imposition does NOT improve the quality of the practice of law and does NOT improve the ability of the practitioner to advocate for his client or to fashion pleadings that exactly conform to his client's best interests. And we should be very wary of the disingenuous pablum about the costs. The courts will find a way to stick it to the practitioner. Lake County is a VERY good example of this rapaciousness. Any one who does not believe this is invited to review the various special fees that system imposes upon practitioners- as practitioners- and upon each case ON TOP of the court costs normal in every case manually filed. Jurisprudence according to Aldous Huxley.

  4. Any attorneys who practice in federal court should be able to say the same as I can ... efiling is great. I have been doing it in fed court since it started way back. Pacer has its drawbacks, but the ability to hit an e-docket and pull up anything and everything onscreen is a huge plus for a litigator, eps the sole practitioner, who lacks a filing clerk and the paralegal support of large firms. Were I an Indiana attorney I would welcome this great step forward.

  5. Can we get full disclosure on lobbyist's payments to legislatures such as Mr Buck? AS long as there are idiots that are disrespectful of neighbors and intent on shooting fireworks every night, some kind of regulations are needed.

ADVERTISEMENT